Donald Olds

Director at Retension Pharmaceuticals · 1 reported transaction in 1 company · latest report Oct 13, 2026

Their trades


Retension PharmaceuticalsRTSN	Converted — · 5,637 shares	Oct 13, 2026

Oct 13, 2026 · RTSN

5,637

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Retension Pharmaceuticals · 1 reported transaction in 1 company · latest report Oct 13, 2026


Retension PharmaceuticalsRTSN	Converted — · 5,637 shares	Oct 13, 2026

Oct 13, 2026 · RTSN

5,637

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.